Great West Life Assurance CO Biocryst Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

$69.9 Billion
Q3 2025

A detailed history of Great West Life Assurance CO transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 60,906 shares of BCRX stock, worth $431,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,906

Previous 60,906 -0.0%

Holding current value

$431,214

Previous $546,000 15.93%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.41 - $11.19 $66,414 - $115,939	10,361 Added 20.5%	60,906 $546,000
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $212,626 - $288,255	33,171 Added 190.92%	50,545 $384,000
Q4 2023 Feb 13, 2024	SELL	$4.98 - $6.77 $222,954 - $303,092	-44,770 Reduced 72.04%	17,374 $103,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $135,629 - $160,086	20,213 Added 48.21%	62,144 $439,000
Q2 2023 Aug 10, 2023	BUY	$6.96 - $8.81 $24,547 - $31,072	3,527 Added 9.18%	41,931 $297,000

Q1 2023 May 12, 2023	BUY	$7.94 - $11.84 $224,567 - $334,870	28,283 Added 279.45%	38,404 $321,000
Q4 2022 Feb 10, 2023	BUY	$10.5 - $14.2 $13,482 - $18,232	1,284 Added 14.53%	10,121 $117,000
Q3 2022 Nov 01, 2022	BUY	$10.79 - $14.81 $95,351 - $130,875	8,837 New	8,837 $111,000
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $13,791 - $23,573	-1,193 Reduced 11.89%	8,837 $153,000
Q2 2021 Aug 11, 2021	SELL	$9.5 - $17.24 $23,959 - $43,479	-2,522 Reduced 20.09%	10,030 $158,000
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $25,684 - $47,430	3,485 Added 38.44%	12,552 $127,000
Q3 2020 Nov 17, 2020	BUY	$3.43 - $5.53 $31,099 - $50,140	9,067 New	9,067 $31,000
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $31,099 - $50,140	-9,067 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.9 - $5.61 $3,782 - $11,169	1,991 Added 28.14%	9,067 $43,000
Q4 2019 Feb 11, 2020	BUY	$1.59 - $3.45 $11,250 - $24,412	7,076 New	7,076 $24,000
Q3 2019 Oct 25, 2019	SELL	$2.5 - $3.73 $33,340 - $49,743	-13,336 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$7.38 - $9.72 $44,545 - $58,669	6,036 Added 82.68%	13,336 $108,000
Q3 2017 Nov 09, 2017	BUY	$4.1 - $5.97 $29,929 - $43,581	7,300	7,300 $38,000

Others Institutions Holding BCRX

# of Institutions

310

Shares Held

200M

Call Options Held

640K

Put Options Held

507K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.32B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Biocryst Pharmaceuticals Inc Transaction History